According to Future Market Insights, the central nervous system lymphoma treatment industry is projected to rise at a steady growth valued at USD 123.2 billion with a 5.2% CAGR until 2033, being valued at USD 205.3 billion. The rapid advancements in diagnostics and therapeutics of the central nervous system (CNS) disease significantly contribute to market …